Design Therapeutics OverviewDesign Therapeutics Other Income Expense Net
Other Income/Expense Net for DSGN.
Quarterly Other Income/Expense
$2.07M
↓ 23.42% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$9.04M
↓ 25.9% YoY
Trailing 12 months ending Mar 31, 2026